1letý cíl společnosti Akorn

Jaká je hodnota metriky 1letý cíl společnosti Akorn?

Hodnota metriky 1letý cíl společnosti Akorn, Inc. je $2 +7,307.41%

Jaká je definice metriky 1letý cíl?

1-letý cíl (1-year target) je analytiky předpokládaná cena akcie za rok od dnešního dne.

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

1letý cíl společností v sektoru Health Care sektor na OTC ve srovnání se společností Akorn

Čemu se věnuje společnost Akorn?

Akorn, Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. Its primary products include Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; and Xopenex inhalation solution used in the treatment or prevention of bronchospasm. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products comprising Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. Further, the company sells its products to wholesale distributors. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois. On May 20, 2020, Akorn, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Firmy s metrikou 1letý cíl podobnou společnosti Akorn



  • Hodnota metriky 1letý cíl společnosti Carbon Revolution je AUD$2 +1,366.67%
  • Hodnota metriky 1letý cíl společnosti Pro Farm Inc je $2 +147.50%
  • Hodnota metriky 1letý cíl společnosti Windward je GBX161 +2.33%
  • Hodnota metriky 1letý cíl společnosti Clever Leaves je $2 +989,900.00%
  • Hodnota metriky 1letý cíl společnosti Beach je AUD$2 +73.04%
  • Hodnota metriky 1letý cíl společnosti LifeSpeak je CAD$2 +362.79%
  • Hodnota metriky 1letý cíl společnosti Akorn je $2 +7,307.41%
  • Hodnota metriky 1letý cíl společnosti Shanghai Jin Jiang International Hotels () je HKD$2 -24.53%
  • Hodnota metriky 1letý cíl společnosti Meridian Mining Uk Societas je CAD$3 +653.12%
  • Hodnota metriky 1letý cíl společnosti BlueCity je $0 -80.71%
  • Hodnota metriky 1letý cíl společnosti Helios Towers plc je $2 -98.18%
  • Hodnota metriky 1letý cíl společnosti Helios Towers PLC je GBX165 +47.69%
  • Hodnota metriky 1letý cíl společnosti Montage Gold je CAD$2 +12.85%